Although first-generation NAMPT inhibitors have demonstrated limited efficacy and significant toxicity in GBM [56], genetic knockdown of NAMPT in GBM cells has been shown to reduce proliferation, migration, and invasion, while promoting apoptosis [53]. The gene discussed is NAMPT; the disease is glioblastoma.